levodopa has been researched along with Obesity in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (60.00) | 18.7374 |
1990's | 5 (12.50) | 18.2507 |
2000's | 6 (15.00) | 29.6817 |
2010's | 4 (10.00) | 24.3611 |
2020's | 1 (2.50) | 2.80 |
Authors | Studies |
---|---|
Aslanoglou, D; Benner, V; Farino, ZJ; Freyberg, Z; Lopez-Valencia, M; McCarthy, MJ; Osborn, O; Wei, H; Zapata, RC | 1 |
Cao, B; Chen, Y; Hou, Y; Liu, H; Ou, R; Shang, H; Song, W; Wei, Q; Yuan, X; Zhang, L | 1 |
Barba, P; Cline, GW; Febres, G; Harris, PE; Korner, J; Leibel, RL; Maffei, A; Rayat, GR; Slifstein, M | 1 |
Cuzzolaro, M; Melchionda, N | 1 |
Calleja-Castillo, J; Cervantes-Arriaga, A; Corona, T; Morales-Briceño, H; Rodríguez-Violante, M | 1 |
Hussain, T; Lokhandwala, MF; Lucas-Teixeira, VA; Serrão, P; Soares-da-Silva, P | 1 |
Dulloo, AG; Montani, JP | 1 |
Mark, GP; Painter, T; Roseberry, AG; Williams, JT | 1 |
Reiner, Z; Sekso, M; Vizner, B | 1 |
Amatruda, JM; Hochstein, M; Hsu, TH; Lockwood, DH | 1 |
Graczykowska-Koczorowska, A; Ponikowska, I | 1 |
Harell, A; Hoerer, E; Laurian, L; Oberman, Z; Wiznitzer, T | 1 |
James, WP; Jung, RT; Liddell, F; Shetty, PS | 1 |
Huh, KB; Kim, KR; Lee, DJ; Lee, EJ; Lee, HC; Lee, JH; Lee, KM; Lim, SK | 1 |
Erkkola, R; Pöllänen, P; Sallinen, K; Su, Y; Wu, X; Zhou, S | 1 |
Huh, KB; Kim, KR; Lee, HC; Lim, SK; Nam, SY; Song, YD | 1 |
Baranowska, B; Borowiec, M; Radzikowska, M; Roguski, K; Wasilewska-Dziubinska, E | 1 |
Cohen, KL | 1 |
James, WP; Jung, RT; Shetty, PS | 1 |
Barbera, N; Buemi, M; Frisina, N; Lasco, A; Nicita-Mauro, V; Squadrito, G | 1 |
Barrand, M; Callingham, BA; James, WP; Jung, RT; Shetty, PS | 1 |
Bellastella, A; Cafaro, MR; D'Alessandro, B; De Luca, R; Esposito, V | 1 |
Barbarine, A; De Marinis, L; Troncone, L | 1 |
Babucke, G; Mertz, DP; Sagebiel, L | 1 |
Banasiak, MF; Kalkhoff, RK; Marshall, WP | 1 |
Bol'shakova, TD; Butrova, SA; Marova, EI; Safronova, NA; Tiabenkova, VF | 1 |
Fierro, A; Giovannini, C; Sartori, MP; Sellini, M | 1 |
Ayalon, D; Cordova, T; Harell, A; Herzberg, M; Horer, E; Laurian, L; Oberman, Z | 1 |
Aranguren, LV; Cabezas-Cerrato, J; Fernández-Cruz, A; Mur, AL; Vila, T | 1 |
Friesen, HG; Pinter, EJ; Tolis, G | 1 |
Balestreri, R; Bertolini, S; Costa, S; Elicio, N | 1 |
Balestreri, R; Barreca, T; Marcenaro, A; Valice, S | 1 |
Balzano, S; Bozzola, M; Carta, D; Faedda, A; Loche, S; Moretta, A; Muntoni, A; Pintor, C; Pintus, S | 1 |
Crist, DM; Skaggs, SR | 1 |
Inoue, S; Numata, K; Saito, M; Shiraki, J; Shishido, T; Takamura, Y; Tanaka, K | 1 |
Inoue, S; Nakamura, S; Numata, K; Okazaki, H; Takamura, Y; Tanaka, K | 1 |
Grzywa, M | 1 |
Delitala, G; Lotti, G; Masala, A | 1 |
Bolduc, R; Gosselin, L; Verreault, R | 1 |
Albanese, MC; Alibrando, S; Allegra, V; Carducci Artenisio, A; Ragonese, F | 1 |
1 review(s) available for levodopa and Obesity
Article | Year |
---|---|
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia | 1977 |
4 trial(s) available for levodopa and Obesity
Article | Year |
---|---|
Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
Topics: Adult; Body Mass Index; Cross-Over Studies; Fatty Acids, Nonesterified; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity; Pituitary Gland; Pyridostigmine Bromide | 1994 |
Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
Topics: Adult; Androgens; Androstenedione; Estradiol; Female; Follicle Stimulating Hormone; Human Growth Hormone; Humans; Infertility, Female; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Obesity; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2000 |
Effect of catecholamine replacement with levodopa on the metabolic response to semistarvation.
Topics: Adaptation, Physiological; Adult; Basal Metabolism; Diet, Reducing; Energy Metabolism; Female; Humans; Levodopa; Norepinephrine; Obesity; Time Factors; Triiodothyronine | 1979 |
Exogenous human growth hormone reduces body fat in obese women.
Topics: Adipose Tissue; Adult; Arginine; Body Composition; Energy Intake; Female; Growth Hormone; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Obesity | 1991 |
35 other study(ies) available for levodopa and Obesity
Article | Year |
---|---|
Dopamine D
Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Female; Glucose; Insulin; Insulin-Secreting Cells; Levodopa; Mice; Mice, Inbred C57BL; Obesity; Receptors, Dopamine D2; Sulpiride; Weight Gain | 2020 |
Vascular risk factors and depression in Parkinson's disease.
Topics: Aged; Alcohol Drinking; Antiparkinson Agents; Anxiety; Asian People; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obesity; Overweight; Parkinson Disease; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Vascular Diseases | 2018 |
A role for foregut tyrosine metabolism in glucose tolerance.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Blood Glucose; Cell Line; Cross-Sectional Studies; Dopamine; Female; Gastrointestinal Tract; Glucose Tolerance Test; Homeostasis; Humans; Insulin; Insulin-Secreting Cells; Levodopa; Male; Nutrients; Obesity; Postprandial Period; Rats; Rats, Inbred Lew; Swine; Tyrosine; Tyrosine 3-Monooxygenase | 2019 |
Parkinson's disease, dopamine, and eating and weight disorders: an illness in the disease?
Topics: Binge-Eating Disorder; Craving; Dopamine; Dopamine Agents; Dopamine Agonists; Food Addiction; Humans; Levodopa; Obesity; Parkinson Disease | 2019 |
Overweight is more prevalent in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Body Mass Index; Case-Control Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mexico; Middle Aged; Obesity; Overweight; Parkinson Disease; Prevalence; Severity of Illness Index; Thinness | 2012 |
Intestinal dopaminergic activity in obese and lean Zucker rats: response to high salt intake.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Catechol O-Methyltransferase; Diabetic Nephropathies; Dopamine; Enzyme Activation; Hyperglycemia; Hypertension, Renal; Jejunum; Levodopa; Male; Monoamine Oxidase; Obesity; Rats; Rats, Zucker; Sodium Chloride, Dietary; Sodium-Potassium-Exchanging ATPase | 2002 |
Obesity in Parkinson's disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends?
Topics: Antiparkinson Agents; Body Mass Index; Brain; Combined Modality Therapy; Dopamine; Electric Stimulation Therapy; Humans; Levodopa; Malnutrition; Obesity; Parkinson Disease; Receptors, Dopamine D2; Subthalamic Nucleus | 2005 |
Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice.
Topics: Animals; Cocaine; Colforsin; Cytoplasmic Vesicles; Dendrites; Dopamine; Dopamine Agonists; Inhibitory Postsynaptic Potentials; Leptin; Levodopa; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Obesity; Organ Culture Techniques; Receptors, Dopamine D2; Receptors, Leptin; Ventral Tegmental Area | 2007 |
Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
Topics: Adult; Blood Glucose; Female; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Middle Aged; Obesity | 1983 |
Hypothalamic and pituitary dysfunction in obese males.
Topics: Adult; Chlorpromazine; Chorionic Gonadotropin; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Luteinizing Hormone; Male; Obesity; Prolactin; Testosterone; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1982 |
[Blood serum growth hormone and insulin concentration in persons with normal body weight, obese patients without carbohydrate intolerance and obese diabetics after L-dopa loading test].
Topics: Adult; Body Weight; Diabetes Mellitus; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Levodopa; Male; Obesity | 1980 |
Growth hormone response to L-dopa in the thinned obese.
Topics: Adolescent; Adult; Body Weight; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Obesity | 1982 |
The effect of levodopa with carbidopa (Sinemet R) on the metabolic response to semistarvation.
Topics: Adaptation, Physiological; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Metabolism; Carbidopa; Diet, Reducing; Drug Combinations; Energy Intake; Female; Humans; Levodopa; Middle Aged; Obesity; Triiodothyronine | 1980 |
The growth hormone (GH)-binding protein in obesity with varying glucose tolerance: relationship with body fat distribution, insulin, GH-insulin-like growth factor (IGF)-I axis and sex hormones.
Topics: Adult; Body Composition; Carrier Proteins; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Obesity; Testosterone | 2000 |
The role of VIP and somatostatin in the control of GH and prolactin release in anorexia nervosa and in obesity.
Topics: Adolescent; Adult; Anorexia Nervosa; Case-Control Studies; Clonidine; Female; Gonadotropin-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Obesity; Prolactin; Somatostatin; Vasoactive Intestinal Peptide | 2000 |
[Obesity and gonadotropins. The pulsatile pattern of LH in obese women].
Topics: Adult; Female; Humans; Levodopa; Luteinizing Hormone; Obesity; Pituitary Gland, Anterior; Placebos | 1979 |
The effect of catecholamine replacement on the metabolic response to semistarvation.
Topics: Adaptation, Physiological; Adult; Basal Metabolism; Catecholamines; Diet, Reducing; Energy Intake; Epinephrine; Humans; Levodopa; Middle Aged; Norepinephrine; Obesity; Starvation; Thyroid Hormones | 1979 |
[Circadian variations in the plasma GH response to L-dopa stimulation in female obesity].
Topics: Circadian Rhythm; Female; Growth Hormone; Humans; Levodopa; Obesity | 1977 |
Growth hormone response to propranolol and L--dopa in obese subjects.
Topics: Adolescent; Adult; Female; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Obesity; Placebos; Propranolol | 1978 |
[Hyperuricemia in Parkinson's syndrome--by chance or probable?].
Topics: Adult; Aged; Female; Gout; Humans; Hypertension; Levodopa; Male; Middle Aged; Obesity; Parkinson Disease, Secondary; Sex Factors; Uric Acid | 1976 |
L-dopa effects on renal function in obese subjects.
Topics: Adult; Diuresis; Female; Humans; Kidney; Levodopa; Obesity; Potassium; Sodium | 1977 |
[Hypothalamo-hypophysal-adrenal interrelations following administration of L-DOPA in patients with Itsenko-Cushing disease and diencephalic obesity].
Topics: Adolescent; Adrenal Glands; Adult; Cushing Syndrome; Diencephalon; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Obesity | 1977 |
[Effect of of L-dropa on the action of plasma cortisol during tests with lysine-8-vasopressin and insulin in essential obesity].
Topics: Adult; Humans; Hydrocortisone; Insulin; Levodopa; Lypressin; Obesity; Pituitary-Adrenal System; Vasopressins | 1977 |
Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects.
Topics: 11-Hydroxycorticosteroids; Administration, Oral; Adolescent; Adult; Antigen-Antibody Reactions; Blood Glucose; Fasting; Fatty Acids, Nonesterified; Female; Growth Hormone; Humans; Insulin; Insulin Secretion; Levodopa; Male; Obesity; Sleep; Time Factors | 1975 |
[Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
Topics: Administration, Oral; Adult; Aged; Female; Growth Hormone; Humans; Injections, Intravenous; Levodopa; Male; Middle Aged; Obesity; Pituitary Gland; Pituitary Gland, Anterior; Propranolol; Stimulation, Chemical | 1975 |
L-dopa, growth hormone and adipokinesis in the lean and the obese.
Topics: Blood Glucose; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Insulin; Levodopa; Lipid Mobilization; Luteinizing Hormone; Male; Obesity; Prolactin; Sex Factors; Thinness | 1975 |
[Action of L-dopa on the response of the hypothalamo-hypophyseal-adrenocortical system to insulin-induced hypoglycemia in normal and obese subjects].
Topics: Adrenal Cortex; Adrenal Glands; Adult; Blood Glucose; Female; Humans; Hydrocortisone; Hypothalamus; Insulin; Levodopa; Male; Middle Aged; Obesity; Pituitary Gland; Pituitary Gland, Anterior | 1975 |
[Action of L-dopa and dopamine on plasma free fatty acids in normal and obese subjects].
Topics: Adult; Dopamine; Fatty Acids, Nonesterified; Female; Humans; Levodopa; Male; Middle Aged; Obesity | 1975 |
Secretion of growth hormone releasing hormone in obese children.
Topics: Child; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Obesity | 1992 |
Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Topics: Adolescent; Adult; Aged; Aging; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Middle Aged; Obesity | 1991 |
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Topics: Adolescent; Adult; Arginine; Body Weight; Diet, Reducing; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Obesity; Weight Loss | 1990 |
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; Propranolol; Somatomedins | 1986 |
Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
Topics: Drug Synergism; Growth Hormone; Humans; Levodopa; Obesity; Practolol; Propranolol; Stimulation, Chemical | 1974 |
[Stimulation of growth hormone (HGH) with L-dopa].
Topics: Adolescent; Adult; Child; Dwarfism; Gigantism; Growth Disorders; Growth Hormone; Humans; Hypopituitarism; Levodopa; Obesity | 1974 |
[Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Fatty Acids, Nonesterified; Growth Hormone; Humans; Insulin; Levodopa; Middle Aged; Obesity; Pituitary Gland | 1974 |